2024–2025 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers

At a glance

During this COCA Call, presenters will provide an overview of influenza prevention and treatment recommendations for the 2024-2025 season from the American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC).

Overview

Influenza remains a serious threat to children because it can cause serious injury or death. Annual influenza vaccination for people 6 months and older is the most effective way to prevent influenza illness and associated complications, including death.

Clinicians play a critical role in promoting influenza vaccination of all children, especially children younger than 5 years, those in higher risk groups, in addition to their family members and caregivers.

During this COCA Call, presenters will provide an overview of influenza prevention and treatment recommendations for the 2024-2025 season from the American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC).

Presenters

Kristina Bryant, MD, FAAP, FPIDS
Member, Committee on Infectious Diseases, American Academy of Pediatrics
Professor of Pediatrics, University of Louisville School of Medicine
Hospital Epidemiologist at Norton Children's Hospital
Medical Director, System Pediatric Epidemiology and Infectious Diseases
Norton Children's Medical Group, Louisville, KY

Tim Uyeki, MD, MPH, MPP, FAAP
Chief Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Call Objectives

Activity-Specific Objectives

  1. Highlight key recommendations in the AAP influenza policy statement, "Recommendations for Prevention and Control of Influenza in Children, 2024-2025" and in the CDC Advisory Committee on Immunization Practices' document, "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2024-2025 Influenza Season."
  2. Review strategies pediatric healthcare providers may implement to increase influenza vaccination rates and highlight current health disparities in vaccination coverage.
  3. Describe considerations and best practices for co-administering influenza vaccines and other childhood immunizations.
  4. List recommendations for influenza testing in outpatient and hospitalized pediatric patients with suspected influenza and describe test limitations.
  5. Review antiviral medications for influenza and CDC recommendations for antiviral treatment of children with suspected or lab-confirmed influenza.

Call Materials

View Slides

Target Audience

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians

Additional Information

  • Contact Information: coca@cdc.gov
  • Support/Funding: Centers for Disease Control and Prevention, Office of Emergency Risk Communication
  • Method of Participation: You may participate in the educational activity by viewing the program information above.